StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the software maker’s stock.
Several other research firms also recently weighed in on MDRX. Royal Bank of Canada dropped their target price on shares of Veradigm from $22.00 to $11.00 and set an outperform rating for the company in a report on Friday, January 19th. Deutsche Bank Aktiengesellschaft reiterated a hold rating and set a $10.00 price target (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Hold and an average price target of $11.25.
View Our Latest Research Report on MDRX
Veradigm Stock Performance
Institutional Investors Weigh In On Veradigm
Hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Management Group LLP grew its holdings in Veradigm by 117.8% in the fourth quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock valued at $60,908,000 after purchasing an additional 3,140,483 shares during the period. Pacer Advisors Inc. grew its holdings in Veradigm by 108.1% in the fourth quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after purchasing an additional 1,307,024 shares during the period. William Blair Investment Management LLC grew its holdings in Veradigm by 16.6% in the third quarter. William Blair Investment Management LLC now owns 4,375,005 shares of the software maker’s stock valued at $57,488,000 after purchasing an additional 623,438 shares during the period. Kent Lake Capital LLC grew its holdings in Veradigm by 62.2% in the fourth quarter. Kent Lake Capital LLC now owns 1,500,000 shares of the software maker’s stock valued at $15,735,000 after purchasing an additional 575,000 shares during the period. Finally, Creative Planning grew its holdings in Veradigm by 2,848.4% in the third quarter. Creative Planning now owns 474,376 shares of the software maker’s stock valued at $6,233,000 after purchasing an additional 458,287 shares during the period.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 5/6 – 5/10
- Stock Average Calculator
- Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
- Upcoming IPO Stock Lockup Period, Explained
- Unity Software’s Mixed Q1, But Long-Term Outlook Remains Positive
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.